XBiotech Inc.XBITNASDAQ
LOADING
|||
XBIT Revenue Growth (YoY Quarterly)•+0.00%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.12% | +0.08% | +0.14% | +0.10% | +0.05% |
| Weighted Average Shares Diluted Growth | +0.12% | +0.08% | +0.14% | +0.10% | +0.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -34.61% | -8.24% | -32.49% | -35.75% | -48.34% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -8.60% | -12.14% | -20.19% | -17.11% | -17.84% |
| Book Value per Share Growth | -13.82% | -16.78% | -16.64% | -12.11% | -13.07% |
| Debt Growth | +0.00% | +0.00% | -100.00% | -100.00% | -100.00% |
| R&D Expense Growth | -5.57% | +0.22% | +18.26% | -58.90% | -28.72% |
| SG&A Expenses Growth | -20.14% | +165.62% | +87.84% | -49.55% | -30.50% |
1 / 4